The EUROclass trial: defining subgroups in common variable immunodeficiency.

C, Wehr; T, Kivioja; C, Schmitt; B, Ferry; T, Witte; E, Eren; M, Vlkova; M, Hernandez; D, Detkova; PR, Bos; G, Poerksen; Bernuth H, von; U, Baumann; S, Goldacker; S, Gutenberger; M, Schlesier; der Cruyssen F, Bergeron-van; Garff M, Le; P, Debré; R, Jacobs; J, Jones; E, Bateman; J, Litzman; Hagen PM, van; A, Plebani; RE, Schmidt; V, Thon; I, Quinti; T, Espanol; AD, Webster; H, Chapel; M, Vihinen; E, Oksenhendler; HH, Peter; K, Warnatz

doi:10.1182/blood-2007-06-091744

Public

The EUROclass trial: defining subgroups in common variable immunodeficiency.

Shared by NobleBlocks on Sep 26, 2007 • 12:00 AM UTC

Authors:

Wehr C

Kivioja T

Schmitt C

Abstract

The heterogeneity of common variable immunodeficiency (CVID) calls for a classification addressing pathogenic mechanisms as well as clinical relevance. This European multicenter trial was initiated to develop a consensus of 2 existing classification schemes based on flowcytometric B-cell phenotyping...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!